• 생명과학회지
• /
• 제14권4호
• /
• pp.620-626
• /
• 2004

2001년부터 2003년까지 3년간 부산지역의 안과 병ㆍ의원으로부터 채취한 급성 바이러스성 결막염 환자의 가검물 675 건을 대상으로 유행한 눈병 원인 바이러스의 분리 결과, 유행성각결막염의 원인바이러스인 Adenovirus 8ㆍ37형, 급성 출혈성결막염(아폴로눈병)의 원인바이러스인 Coxsackievirus A24ㆍB3형, Echovirus 6ㆍ7형을 분리하였고 인두결막열을 일으키는 Adenovirus 3ㆍ4형을 분리하였으며 Coxsackievirus A24는 2002년 아폴로눈병의 대유행과 관련하여 2002 년 8월 국내 최초로 분리하였다. 2002년과 2003년에 분리된 Coxsackievirus B3와 Echovirus 6은 지금까지 뇌수막염을 유발시키는 원인바이러스로 널리 알려져 있으나, 눈병환자에서의 분리된 것은 특징적이었다. 월별 발생양상은 주로 하절기에 집중적으로 분포하였고, 2003년에는 4월과 10월에도 높은 발생율을 보였다. 연령별 발생분포도는 10대에서 50대까지 높은 발생율을 나타내었고 유아와 60대 이상에서도 발생하였고 남녀 발생비는 1.2ㆍ1이었다.

• IMMUNE NETWORK
• /
• 제22권2호
• /
• pp.19.1-19.20
• /
• 2022

Coxsackievirus B3 (CVB3) infection causes acute pancreatitis and myocarditis. However, its pathophysiological mechanism is unclear. Here, we investigated how lipid metabolism is associated with exacerbation of CVB3 pathology using high-fat diet (HFD)-induced obese mice. Mice were intraperitoneally inoculated with 1×10⁶ pfu/mouse of CVB3 after being fed a control or HFD to induce obesity. Mice were treated with mitoquinone (MitoQ) to reduce the level of mitochondrial ROS (mtROS). In obese mice, lipotoxicity of white adipose tissue-induced inflammation caused increased replication of CVB3 and mortality. The coxsackievirus adenovirus receptor increased under obese conditions, facilitating CVB3 replication in vitro. However, lipid-treated cells with receptor-specific inhibitors did not reduce CVB3 replication. In addition, lipid treatment increased mitochondria-derived vesicle formation and the number of multivesicular bodies. Alternatively, we found that inhibition of lipid-induced mtROS decreased viral replication. Notably, HFD-fed mice were more susceptible to CVB3-induced mortality in association with increased levels of CVB3 replication in adipose tissue, which was ameliorated by administration of the mtROS inhibitor, MitoQ. These results suggest that mtROS inhibitors can be used as potential treatments for CVB3 infection.

• Clinical and Experimental Pediatrics
• /
• 제60권10호
• /
• pp.333-336
• /
• 2017

Coxsackievirus A16 (CA16), which primarily causes hand, foot, and mouth disease (HFMD), is associated with complications, such as encephalitis, acute flaccid paralysis, myocarditis, pericarditis, and shock. However, no case of pancreatitis associated with CA16 has been reported in children. We report a case of CA16-associated acute pancreatitis in a 3-year-old girl with HFMD. She was admitted because of poor oral intake and high fever for 1 day. Maculopapular rashes on both hands and feet and multiple vesicles on the soft palate were observed on physical examination. She was treated conservatively with intravenous fluids. On the fourth hospital day, she had severe abdominal pain and vomiting. The serum levels of amylase and lipase were remarkably elevated (amylase, 1,902 IU/L; reference range, 28-100 IU/L; lipase, >1,500 IU/L; reference range, 13-60 IU/L), and ultrasonography showed diffuse swelling of the pancreas with a small amount of ascites. The real-time reverse transcription polymerase chain reaction result from a stool sample was positive for CA16. CA16 can cause acute pancreatitis, and should be considered in the differential diagnosis of abdominal pain in children with HFMD.

• 대한의생명과학회지
• /
• 제26권4호
• /
• pp.302-309
• /
• 2020

Human Coxsackievirus B5 (HuCoxV-B5) infection has been associated with various diseases such as myocarditis, aseptic meningitis, hand-foot-and mouth-disease, and insulin-dependent diabetes. HuCoxV-B5 is a virus transmitted through the fecal-oral route and is detected in clinics, aquatic environments, food, shellfish, etc. and is one of the more important viruses in public health because of its incidence rate reported worldwide. In this study, a combination of SYBR Green-based real-time PCR primers for molecular diagnosis including monitoring of HuCoxV-B5 was selected and the optimal reaction conditions were established. Compared with the previously reported TaqMan probe-based real-time PCR method, assessments including a sample applicability test were performed. Results showed that the real-time PCR method developed in this study was suitable for a molecular diagnostic technique for detecting HuCoxV-B5. This study is expected to contribute to efforts in responding to safety accidents in public health because the proposed method facilitates rapid diagnosis of clinical patients. It can also be used as a specific monitoring tool of HuCoxV-B5 in non-clinical areas such as aquatic environments among others.

• Pediatric Infection and Vaccine
• /
• 제5권1호
• /
• pp.115-120
• /
• 1998

목 적 : 1997년 하절기에도 부산지역에서는 소아에서 무균성 뇌막염이 유행하였다. 이는 1990년대에 들어서 1990년, 1993년, 1996년에 이어 4번째의 유행으로서 전국적인 유행의 일부였다. 이에 저자들은 1997년 하절기에 부산지역에 유행하였던 소아의 무균성 뇌막염의 특징을 알아보고, 이를 문헌 고찰과 함께 보고하는 바이다. 대상 및 방법 : 1997년 4월 상순부터 10월 하순까지 부산 성분도 병원 소아과에 입원하여 임상증상 및 뇌척수액 검사상 뇌막염소견을 보이며 세균배양 검사상 균이 자라지 않는 환아 265명을 대상으로 하였다. 결 과 : 1) 성별분포는 남아 167례(63%), 여아 98(37%)로 남녀비는 1.7:1 이었다. 2) 평균 연령은 $6.2{\pm}3.29$세였다. 3) 유행시기는 4~10월이었다. 4) 임상증상은 발열 99.6%, 구토 99.2%, 두통 99.2% 발진 6.0%였다. 5) 발열기간은 $3.34{\pm}2.21$일이었다. 6) 입원기간은 $5.3{\pm}3.21$일이었다. 7) 혈액검사상 백혈구수는 $11,200{\pm}4,163/mm^3$이었다. 8) 뇌척수액 검사상 백혈구수는 $156.1{\pm}394.7/mm^3$이었다. 9) 원인 바이러스는 coxsackievirus B5, echovirus 6, 30, type nonspecific enterovirus 등이 검출되었다. 결 론 : 1997년 유행한 무균성 뇌막염은 1996년 유행한 무균성 뇌막염과 비교해 보았을 때, 발생연령이 증가하였고, 발열기간과 발진의 빈도가 감소하여 전반적인 임상증상은 경하였다. 유행시기는 4~10월로, 1996년 5~10월과 차이가 없었으며 원인 바이러스는 coxsackievirus B5, echovirus 6, 30, type nonspecific enterovirus이었고, 1996년은 echovirus 9, coxsackievirus A24, type nonspecific enterovirus였다.

• 한국미생물학회:학술대회논문집
• /
• 한국미생물학회 2003년도 International Meeting of the Microbiological Society of Korea
• /
• pp.93-94
• /
• 2003

• 한국미생물학회:학술대회논문집
• /
• 한국미생물학회 2007년도 International Meeting of the Microbiological Society of Korea
• /
• pp.43-45
• /
• 2007

• Journal of Microbiology and Biotechnology
• /
• 제28권1호
• /
• pp.109-114
• /
• 2018

Coxsackievirus Type B3 (CVB3) is an enterovirus that belongs to the Picornaviridae and causes various diseases such as myocarditis and hand-foot-mouth disease. However, an effective antiviral drug is still not developed. In this study, we looked for potential inhibitors of CVB3 replication by examining the survival of CVB3-infected HeLa cells. We detected an antiviral effect by cholic acid and identified it as a candidate inhibitor of CVB3 replication. Cholic acid circulates in the liver and intestines, and it helps the digestion and absorption of lipids in the small intestine. HeLa cells were cultured in 12-well plates and treated with cholic acid (1 and $10{\mu}g/ml$) and $10^6PFU/ml$ of CVB3. After 16 h post-infection, the cells were lysed and subjected to western blot analysis and RT-PCR. The production of the viral capsid protein VP1 was dramatically decreased, and translation initiation factor eIF4G1 cleavage was significantly inhibited by treatment with $10{\mu}g/ml$ cholic acid. Moreover, cholic acid inhibited ERK signaling in CVB3-infected HeLa cells. RT-PCR showed that the amounts of the CVB3 RNA genome and mRNA for the ER stress-related transcription factor ATF4 were significantly reduced. These results showed that cholic acid strongly reduced ER stress and CVB3 proliferation. This compound can be developed as a safe natural therapeutic agent for enterovirus infections.

• 생명과학회지
• /
• 제19권3호
• /
• pp.373-377
• /
• 2009

환경시료에서 많이 분리되는 장내바이러스 중 폴리오바이러스, 콕사키바이러스, 에코바이러스를 이용하여 정수처리 공정별 제거율을 조사하였다. 양성 시료로 사용된 바이러스들의 회수율은 72-108%의 범위로 나타났다. 이들 3종 바이러스들을 대상으로 정수처리공정별 제거효율을 조사한 결과 약 99%의 바이러스가 침전단계에서 제거되어졌고, 후오존과 BAC 여과과정을 거치면서 100% 제거되어짐을 확인할 수 있었다. 6개의 세포주를 사용하여 바이러스별 감수성을 조사한 결과 폴리오바이러스는 BGMK 세포주, 콕사키바이러스는 Vero 및 BGMK 세포주가 다른 세포주에 비해 높은 감수성을 나타내었고, 반면 에코바이러스는 RD 세포주에서 가장 분리가 용이하였다.

• Biomolecules & Therapeutics
• /
• 제23권5호
• /
• pp.465-470
• /
• 2015

Chrysin is a 5,7-dihydroxyflavone and was recently shown to potently inhibit enterovirus 71 (EV71) by suppressing viral 3C protease ($3C^{pro}$ activity. In the current study, we investigated whether chrysin also shows antiviral activity against coxsackievirus B3 (CVB3), which belongs to the same genus (Enterovirus) as EV71, and assessed its ability to prevent the resulting acute pancreatitis and myocarditis. We found that chrysin showed antiviral activity against CVB3 at $10{\mu}M$, but exhibited mild cellular cytotoxicity at $50{\mu}M$, prompting us to synthesize derivatives of chrysin to increase the antiviral activity and reduce its cytotoxicity. Among four 4-substituted benzyl derivatives derived from C(5) benzyl-protected derivatives 7, 9-11 had significant antiviral activity and showed the most potent activity against CVB3 with low cytotoxicity in Vero cells. Intraperitoneal injection of CVB3 in BALB/c mice with $1{\times}10^6TCID_{50}$ (50% tissue culture infective dose) of CVB3 induced acute pancreatitis with ablation of acinar cells and increased serum CXCL1 levels, whereas the daily administration of 9 for 5 days significantly alleviated the pancreatic inflammation and reduced the elevation in serum CXCL1 levels. Collectively, we assessed the anti-CVB3 activities of chrysin and its derivatives, and found that among 4-substituted benzyl derivatives, 9 exhibited the highest activity against CVB3 in vivo, and protected mice from CVB3-induced pancreatic damage, simultaneously lowering serum CXCL1 levels.